These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7902553)

  • 1. Efficacy of dapiprazole.
    Johnson ME; Molinari JF
    Optom Vis Sci; 1993 Oct; 70(10):818-21. PubMed ID: 7902553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapiprazole clinical efficiency for counteracting tropicamide 1%.
    Molinari JF; Johnson ME; Carter J
    Optom Vis Sci; 1994 May; 71(5):319-22. PubMed ID: 7915025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of dapiprazole with hydroxyamphetamine hydrobromide and tropicamide.
    Johnson ME; Molinari JF; Carter J
    J Am Optom Assoc; 1993 Sep; 64(9):629-33. PubMed ID: 7901258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical efficacy of paremyd with and without dapiprazole in subjects with light and dark brown irides.
    Anicho UM; Cooper J; Feldman J; Jaanus SD; Dignam K
    Optom Vis Sci; 1999 Feb; 76(2):94-101. PubMed ID: 10082055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of dapiprazole on accommodative amplitude in eyes dilated with 0.5 percent tropicamide.
    Nyman N; Reich L
    J Am Optom Assoc; 1993 Sep; 64(9):625-8. PubMed ID: 7901257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dapiprazole's effect upon accommodative recovery: is it due entirely to changes in depth of field?
    Molinari JF; Carter JH; Johnson ME
    Optom Vis Sci; 1995 Aug; 72(8):552-6. PubMed ID: 8539022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects on pupil size and accommodation of three regimens of topical dapiprazole.
    Wilcox CS; Heiser JF; Crowder AM; Wassom NJ; Katz BB; Dale JL
    Br J Ophthalmol; 1995 Jun; 79(6):544-8. PubMed ID: 7626570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response study of dapiprazole HCl in the reversal of mydriasis induced by 2.5% phenylephrine.
    Hogan TS; McDaniel DD; Bartlett JD; Hart KK; Paggiarino DA
    J Ocul Pharmacol Ther; 1997 Aug; 13(4):297-302. PubMed ID: 9261765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical use of mydriasis with 10% phenylephrine and its antagonism by 0.5% dapiprazole].
    Schimidbauer JM; Höh H; Franke G; Petsch E; Siegmund W
    Ophthalmologe; 1999 Mar; 96(3):182-6. PubMed ID: 10234966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dapiprazole on the reversal of pharmacologically induced mydriasis.
    Nyman N; Keates EU
    Optom Vis Sci; 1990 Sep; 67(9):705-9. PubMed ID: 1978275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical efficacy of Rev-Eyes in reversing the effects of pupillary dilation.
    Connor CG; Campbell JB; Tirey WW
    J Am Optom Assoc; 1993 Sep; 64(9):634-6. PubMed ID: 7901259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The additive miotic effects of dapiprazole and pilocarpine.
    Geyer O; Loewenstein A; Shalmon B; Neudorfer M; Lazar M
    Graefes Arch Clin Exp Ophthalmol; 1995 Jul; 233(7):448-51. PubMed ID: 7557512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of mydriasis by dapiprazole.
    Allinson RW; Gerber DS; Bieber S; Hodes BL
    Ann Ophthalmol; 1990 Apr; 22(4):131-3, 138. PubMed ID: 1972008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dapiprazol antagonizes tropicamide- and phenylephrine-induced mydriasis in the elderly].
    Warlich M; Weik R; Höh H; Ruprecht KW
    Ophthalmologe; 1995 Apr; 92(2):179-81. PubMed ID: 7780277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of combined instillation of dapiprazole and epinephrine on human anterior chamber depth, intraocular pressure and pupil diameter].
    Sugiyama T; Matsuda K; Tokuoka S; Sato B; Azuma I
    Nippon Ganka Gakkai Zasshi; 1989 Apr; 93(4):449-52. PubMed ID: 2572162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intraocular dapiprazole in the rabbit eye.
    Bonomi L; Marchini G; Pagello P; Simonazzi A; Durando L; Ciarniello MG
    J Cataract Refract Surg; 1989 Nov; 15(6):681-4. PubMed ID: 2614713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the clinical pharmacokinetics of pilocarpine, moxisylyte (thymoxamine), and dapiprazole in the reversal of diagnostic pupillary dilation.
    Doughty MJ; Lyle WM
    Optom Vis Sci; 1992 May; 69(5):358-68. PubMed ID: 1350669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapiprazole: will it affect the standard of care for pupillary dilation?
    Bartlett JD; Classé JG
    Optom Clin; 1992; 2(4):113-20. PubMed ID: 1363078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phentolamine Eye Drops Reverse Pharmacologically Induced Mydriasis in a Randomized Phase 2b Trial.
    Karpecki PM; Foster SA; Montaquila SM; Kannarr SR; Slonim CB; Meyer AR; Sooch MP; Jaber RM; Charizanis K; Yousif JE; Klapman SA; Amin AT; McDonald MB; Horn GD; Lazar ES; Pepose JS
    Optom Vis Sci; 2021 Mar; 98(3):234-242. PubMed ID: 33633016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ibopamine on aqueous humor production in normotensive humans.
    McLaren JW; Herman DC; Brubaker RF; Nau CB; Wayman LL; Ciarniello MG; Rosignoli MT; Dionisio P
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4853-8. PubMed ID: 14578408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.